Clinical Trials Office
David Madoff, MD
Vice Chair for Clinical Research
Lawrence Saperstein, MD
Medical Director for Clinical Trials
Todd Schlachter, MD
Co-Medical Director for Clinical Trials
Eliot Funai, CCRP
Clinical Research Assistant Manager
Interventional Oncology and Clinical Trials
The Interventional Oncology Lab is comprised of a team of faculty, post-doctorate researchers, scientists, medical students, residents, and fellows all with the goal of furthering research in interventional oncology by improving the detection, characterization, and treatment of cancers in the liver. This includes research in basic science developing anti-cancer therapies; translational pre-clinical research bringing innovations from the laboratory to clinical use; clinical clinicalm, research on improving current intra-arterial therapies and procedural imaging; and clinical trials that offer new treatment options for patients with liver cancer, including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and liver metastases from a secondary cancer.
For more information please view current diagnostic and interventional radiology trials.
Yale Sponsored Projects Handbook and Principal Investigators Policies